Blood test could predict when melanoma treatments stop working
NCT ID NCT04866680
Summary
This study aims to see if tracking tiny pieces of tumor DNA in the blood can help doctors predict when melanoma treatments might stop working. Researchers will follow 136 adults with stage IIB-IV melanoma who are having surgery followed by standard drug therapy. The goal is to learn if changes in this 'circulating tumor DNA' can signal treatment resistance earlier than current methods.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CGFL
Dijon, France
-
CHU Jean Minjoz
Besançon, France
-
Chru Lille
Lille, France
-
Chru Nancy
Vandœuvre-lès-Nancy, France
-
Chu Dijon
Dijon, France
-
Ghr Mulhouse Sud Alsace
Mulhouse, France
-
Institut Godinot
Reims, 51100, France
-
Institut de Cancerologie de Lorraine
Vandœuvre-lès-Nancy, 54519, France
Conditions
Explore the condition pages connected to this study.